New antibody targets cancer-causing HER2 mutations

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer.

Too many donor organs go to waste. Here’s how to get them into the patients who need them

As I was getting ready to perform a kidney transplant from a deceased donor on a recent Saturday afternoon, my phone rang. When I saw

March 2, 2024

Bristol Myers nabs approval for Opdivo combo as first-line bladder cancer treatment

Bristol Myers Squibb won another approval for its blockbuster cancer drug Opdivo, this time to treat a type of bladder cancer in combination with chemotherapies,

March 8, 2024

Dementia Diagnoses in Primary Care

Negotiations are underway in medical literature and clinics as to who should diagnose dementia, in light of new anti-amyloid monoclonal antibodies — lecanemab (Leqembi) and

July 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.